| |
| |
|
| Insider
Information: |
Drake Peter F |
| Relationship: |
10% Owner |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
309,237 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
309,237 |
|
|
| Total
Value |
$11,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2005-04-13 |
0 |
Premium* |
|
|
RespireRx Pharmaceuticals Inc |
RSPI |
Director |
2007-11-14 |
50,000 |
2007-11-14 |
0 |
Premium* |
|
|
Rodman & Renshaw Capital |
RDRN |
Director |
2011-05-06 |
118,868 |
2007-12-04 |
0 |
Premium* |
|
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2015-07-16 |
77,829 |
2011-09-15 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
62,540 |
2019-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
62,540 |
62,540 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2015-07-16 |
4 |
D |
$0.01 |
$220 |
D/D |
(22,000) |
77,829 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2015-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
99,839 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2015-02-05 |
4 |
A |
$1.89 |
$14,375 |
D/D |
7,606 |
77,829 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2014-11-10 |
4 |
A |
$1.32 |
$14,484 |
D/D |
10,973 |
70,223 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2014-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
59,250 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
39,250 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
27,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2011-09-15 |
4 |
B |
$3.08 |
$30,780 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| RDRN |
Rodman & Renshaw Capital |
Director |
– • – |
2011-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
49,768 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,263) |
0 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-04-01 |
4 |
A |
$3.46 |
$7,750 |
D/D |
2,240 |
100,263 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-02-19 |
4 |
A |
$2.50 |
$250 |
D/D |
100 |
98,023 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-01-04 |
4 |
A |
$0.00 |
$7,001 |
D/D |
8,662 |
97,923 |
0 |
- |
|
| RDRN |
Rodman & Renshaw Capital |
Director |
– • – |
2009-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
39,768 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2009-10-02 |
4 |
A |
$2.13 |
$6,999 |
D/D |
3,286 |
89,261 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,536 |
85,975 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2009-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
83,439 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2009-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
71,439 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,192 |
67,439 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,705 |
57,247 |
0 |
- |
|
| RDRN |
Rodman & Renshaw Capital |
Director |
– • – |
2008-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,768 |
9,768 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,955 |
55,542 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
346 |
51,587 |
0 |
- |
|
| RDRN |
Rodman & Renshaw Capital |
Director |
– • – |
2008-08-15 |
4 |
B |
$2.27 |
$113,265 |
D/D |
50,000 |
69,100 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
